Enrolling by invitationPhase 3NCT05426733
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Studying Isolated biliary atresia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Albireo, an Ipsen Company
- Intervention
- Odevixibat(drug)
- Enrollment
- 180 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2028
Study locations (30)
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's Healhcare of Atlanta- Emory University school of medicine, Atlanta, Georgia, United States
- Indiana University school of Medicine, Indianapolis, Indiana, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Children's Mercy Hospital and Clinics, Kansas City, Missouri, United States
- Hassenfeld Children's Hospital at NYU Langone, New York, New York, United States
- Columbia University Medical Center New York Presbyterian Morgan Stanley-Komansky Childrens Hospital, New York, New York, United States
- The Childrens Hospital at Montefiore Albert Einstein School of Medicine, The Bronx, New York, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- Royal Children's Hospital, Parkville, Australia
- CHU Sainte-Justine, Montreal, Canada
- The Hospital for Sick Children, Toronto, Canada
- Guangzhou Women And Childrens Medical Center, Guangdong, China
- Children's Hospital of Fudan University, Shanghai, China
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05426733 on ClinicalTrials.govOther trials for Isolated biliary atresia
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07250854The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal CholestasisUniversity of Alabama at Birmingham
- RECRUITINGNANCT06764082Nutritional Intervention for Biliary AtresiaTongji Hospital
- RECRUITINGNANCT06564740Stem Cell Applications in Biliary Atresia PatientsNecmi Kadıoğlu Hospital
- ACTIVE NOT RECRUITINGNCT06184971Biliary Atresia Research Network NortheastYale University
- RECRUITINGNCT05848310Preoperative Serum FGF19 in the Prognosis of Biliary AtresiaChildren's Hospital of Fudan University
- RECRUITINGNANCT05925309Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai PortoenterostomyChildren's Hospital of Fudan University
- RECRUITINGNCT05072626High Medium-chain Triglyceride Nutritional Support in Infants With Biliary AtresiaChildren's Hospital of Fudan University
- RECRUITINGNANCT04272515Molecular Characterization for Understanding Biliary AtresiaInstitut National de la Santé Et de la Recherche Médicale, France